Understanding omega-3's.
暂无分享,去创建一个
[1] J. Altimiras,et al. Letter regarding article by Khan et al, "predictive adaptive responses to maternal high-fat diet prevent endothelial dysfunction but not hypertension in adult rat offspring". , 2005, Circulation.
[2] D. Mozaffarian,et al. Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men , 2005, Circulation.
[3] T. Rohan,et al. Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. , 2004, The Journal of nutrition.
[4] R. Beckstrand,et al. Treatment of Hypertriglyceridemia With Omega‐3 Fatty Acids: A Systematic Review , 2004, Journal of the American Academy of Nurse Practitioners.
[5] J. Manson,et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. , 2004, The Journal of nutrition.
[6] M. Katan,et al. Dietary α-Linolenic Acid Is Associated with Reduced Risk of Fatal Coronary Heart Disease, but Increased Prostate Cancer Risk: A Meta-Analysis , 2004 .
[7] G. Burdge. Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. , 2004, Current opinion in clinical nutrition and metabolic care.
[8] J. Lau,et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. , 2004, Evidence report/technology assessment.
[9] J Lau,et al. Effects of omega-3 fatty acids on cardiovascular disease. , 2004, Evidence report/technology assessment.
[10] V. Rastogi,et al. Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4 , 1997, Cardiovascular Drugs and Therapy.
[11] M. Katan,et al. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. , 2004, The Journal of nutrition.
[12] Michael L. Green. Management of dyslipidemias in the age of statins. , 2003, Primary care.
[13] K. Lewandrowski,et al. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? , 2003, Archives of pathology & laboratory medicine.
[14] Laszlo Magos,et al. The toxicology of mercury--current exposures and clinical manifestations. , 2003, The New England journal of medicine.
[15] E. Rimm,et al. Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women , 2003, Circulation.
[16] Christopher Cox,et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study , 2003, The Lancet.
[17] Lawrence J Appel,et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[18] P Hugh R Barrett,et al. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. , 2002, Diabetes.
[19] G. Watts,et al. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity , 2002, European journal of clinical investigation.
[20] E. Whitley,et al. The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART) , 2002, European Journal of Clinical Nutrition.
[21] J. Manson,et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.
[22] J. Manson,et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. , 2002, JAMA.
[23] T. A. Jacobson,et al. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. , 2001, Archives of internal medicine.
[24] Maurice Sokolow,et al. American Heart Journal , 2001 .
[25] A. Farmer,et al. Fish oil in people with type 2 diabetes mellitus. , 2001, The Cochrane database of systematic reviews.
[26] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[27] ichard,et al. FISH CONSUMPTION AND THE 30-YEAR RISK OF FATAL MYOCARDIAL INFARCTION , 2000 .
[28] A. Simopoulos,et al. Essential fatty acids in health and chronic disease. , 1999, The American journal of clinical nutrition.
[29] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[30] Roberto Marchioli,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .
[31] M. de Lorgeril,et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. , 1999, Circulation.
[32] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[33] Jean-Louis Martin,et al. Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction Final Report of the Lyon Diet Heart Study , 1999 .
[34] N. Sheard. Fish consumption and risk of sudden cardiac death. , 2009, Nutrition reviews.
[35] R. Berge,et al. Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia , 1998, Journal of internal medicine.
[36] Center for Food Safety and Applied Nutrition. , 1997, Nutrition reviews.
[37] K. Yano,et al. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. , 1996, Circulation.
[38] E. Rimm,et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. , 1995, The New England journal of medicine.
[39] P. Touboul,et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.
[40] T. Dolecek,et al. Epidemiological Evidence of Relationships between Dietary Polyunsaturated Fatty Acids and Mortality in the Multiple Risk Factor Intervention Trial , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[41] P. Weber,et al. Cardiovascular Effects of ω3 Fatty Acids , 1991 .
[42] P. Allhoff,et al. The Honolulu Heart Program , 1991 .
[43] P. Weber,et al. Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids. , 1991, World review of nutrition and dietetics.
[44] M. Katan,et al. Lower ratio of n-3 to n-6 fatty acids in cultured than in wild fish. , 1990, The American journal of clinical nutrition.
[45] P. Weber,et al. Clinical studies on the effects of n‐3 fatty acids on cells and eicosanoids in the cardiovascular system , 1989, Journal of internal medicine. Supplement.
[46] P. Elwood,et al. EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.
[47] H. Sewell,et al. CYTOCHROME P-450 IMMUNOLOCALISATION IN HUMAN LIVER , 1986, The Lancet.
[48] A. Simopoulos,et al. Purslane: a terrestrial source of omega-3 fatty acids. , 1986, The New England journal of medicine.
[49] D Kromhout,et al. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.
[50] S. Eaton,et al. Paleolithic nutrition. A consideration of its nature and current implications. , 1985, The New England journal of medicine.
[51] J. Vane,et al. EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS? , 1978, The Lancet.
[52] M. Crawford,et al. Fatty-acid ratios in free-living and domestic animals. Possible implications for atheroma. , 1968, Lancet.
[53] U. Essers,et al. CANCER RESEARCH: SOME FORWARD STEPS. , 1965, Lancet.
[54] J. Lenihan,et al. Staff-location systems suitable for hospital use. , 1958, Lancet.